|Bid||17.31 x 200|
|Ask||17.33 x 300|
|Day's Range||16.81 - 18.14|
|52 Week Range||15.22 - 51.51|
|PE Ratio (TTM)||-2.78|
|Dividend & Yield||1.10 (6.10%)|
|1y Target Est||N/A|
Teva Pharmaceutical Industries Ltd. shares rose 2.3% in premarket trade Tuesday after the company announced it has made amendments to its U.S. dollar and Japanese yen term loan and revolving credit facilities, ...
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock is off more than 50% so far this year. This is one of the leading generic drug producers in the world. Unfortunately, U.S. courts changed the dynamic by allowing more generics competition sooner than TEVA counted on.
Teva Pharmaceutical Industries Ltd. will sell the remaining assets in its specialty global women’s health business for $1.38 billion, the company’s latest move to grapple with high debt.